Navigation Links
VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ
Date:10/13/2009

heart attack and stroke. In addition, VIA's pipeline of drug candidates includes other compounds to address other underlying causes of cardiovascular disease: high cholesterol, diabetes and inflammation. For more information, visit: http://www.viapharmaceuticals.com.

Forward Looking Statements

This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to VIA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:

  • our ability to comply with the NASDAQ rules for continued listing;
  • our ability to borrow additional amounts under the loan from Bay City Capital, which is subject to the discretion of Bay City Capital;
  • our ability to obtain necessary financing in the near term, including amounts necessary to repay the loan from Bay City Capital by the October 31, 2009 matur
    '/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
2. Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
3. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
4. Onyx Pharmaceuticals to Acquire Proteolix, Inc.
5. Onyx Pharmaceuticals Announces Investor Teleconference and Webcast
6. ADVENTRX Pharmaceuticals Announces Closing of Financing
7. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
8. Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
9. Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
10. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
11. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., NEW YORK, Nov. 20 Reportlinker...s available in its catalogue. ,, Medical Adhes...tp://www.reportlinker.com/p0164242/Medical-Adhesiv...ce=prnewswire&utm_medium=pr&utm_campaign=p... sealants is gaining preeminence in medical device...
(Date:11/20/2009)..., PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire-USNew... article that questions why currently available me...rs are being ignored, ECRI Institute, an independe...o the evidence on Finasteride for Prevention of P...ember 13, 2009, New York Times article, " Drugs ...
(Date:11/19/2009)...ARDEE, Ireland, Nov. 19 Warner Chi...cing of its previously announced secondary offerin...to the public of $22.25 per share. The selling sh...tal Partners, DLJ Merchant Banking, J.P. Morgan Pa... Partners, L.P., certain other institutional inves...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4 26amp 3B 238220 3BThink Outside the Box 26amp 3B 238221 3B Blog Proposes Better Abortion Compromise for Health Reform 61043 1 26amp 3B 238220 3BThink Outside the Box 26amp 3B 238221 3B Blog Proposes Better Abortion Compromise for Health Reform 61043 2Ultrasonic Cleaner from Tovatech Plays Key Role in World Health Organization 26apos 3Bs Guidelines for Infection Control 61039 1Ultrasonic Cleaner from Tovatech Plays Key Role in World Health Organization 26apos 3Bs Guidelines for Infection Control 61039 2Ultrasonic Cleaner from Tovatech Plays Key Role in World Health Organization 26apos 3Bs Guidelines for Infection Control 61039 3Seattle Law Firm Carrington Nuamah Launches New Website for Personal Injury Bankruptcy Immigration and Estate Law 61035 1Seattle Law Firm Carrington Nuamah Launches New Website for Personal Injury Bankruptcy Immigration and Estate Law 61035 2
...ults inconclusive, as primary outcome measure not ... or AZD3480; results impacted by improvement i...ry outcome measures ADCS-CGIC and MMSE, -- Overal...acebo, with fewer GI-related AEs than donepezi... dataset and planned discussions with leading ...
...tion Bias, DURHAM, N.C., Sept. 15 Less than 20 p...atment are eventually published in,medical journal...the,journal "The Oncologist.", (LOGO: http://www... Drs. Scott Ramsey and John Scoggins of University... Center, Seattle, searched the National,Institutes...
Other Medicine Technology:AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 4Most Cancer Treatment Studies Aren't Published, Study Finds 2Most Cancer Treatment Studies Aren't Published, Study Finds 3
(Date:11/21/2009)... NH based medical credentialing sof...s industry to form a partnerhsip with Amerinet, In...s partnership will help to transform quality care ... (Vocus) November 21, 2009 -- ISG Group, LLC...ed a new agreement with Amerinet Inc., a leading n...
(Date:11/21/2009)... New Haven Dental Group merges thei...f Branford, CT. , (PRWEB)...comprised of partners Dr. David Gibson, Dr. Dean C...er has just merged their growing practice with tha...,When Dr. Pickman decided he wanted to retire from...
(Date:11/20/2009)..., WASHINGTON, Nov. 20 ...nators to modify health care reform legislation re...rding a health insurance individual coverage manda...ceable mandate will minimize adverse selection ste... prescribed by the bill. ,, "The individual man...
(Date:11/20/2009)..., MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ ...irus may have peaked in late October, but the pand...of illness in all age groups, including the elderl...Incorporated (NYSE: DGX ), the world,s leading p...vices. ,, In its most recent Quest Diagnostics...
(Date:11/20/2009)... WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNewswi... a mission to redefine what it means to be "happy"...ounselor with a specialty in family counseling and...est University, Gladding says research shows that ... sadness and even depression during the holidays. ...
Breaking Medicine News(10 mins):Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2
... CALL AND WEBCAST TO FOLLOW, BIRMINGHAM, Ala., No...X ) today announced that its third quarter,2007 fi...mber 8, 2007. At,10:00 a.m. Eastern Time, BioCryst...ior Vice President and Chief,Financial Officer. Bi...
... Nov. 6 /PRNewswire-FirstCall/ - Response Biomedic...ed to announce that the,Toronto Stock Exchange (TS...ation for listing its common shares on the TSX. Li... listing approval,has been granted by the TSX. Ab...
...affirms Earnings Guidance and Provides Updated Rev...007, BIRMINGHAM, Ala., Nov. 6 Emageon Inc.,(Nasd...ts third quarter and,nine months ended September 3...as,$4.3 million, or $0.20 per share. In the third ...
...ce, November 6 Sanofi Pasteur, the,vaccines divis...ive results,in the development of a vaccine for th...t widespread tropical diseases. The results are be...hese results have prompted Sanofi Pasteur to immed...
...k geared to genetic blueprints from Elite Books, .... It,plays a key role in the development of Alzhei... of chronic ailments. And it is greatly affected,b...lite, Hardcover, $27.95, November 1, 2007), Pamela...
...EIRO, Brazil, Nov. 5 One of,Brazil,s leading dist...ribuidora de Produtos Farmaceuticos S.A. ("Profarm...ounced its results for the third quarter of,2007 (... being prepared on consolidated bases in accordanc...
Other Medicine News:Health News:BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007 2Health News:BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007 3Health News:BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007 4Health News:Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 2Health News:Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 3Health News:Emageon Reports Third Quarter 2007 Financial Results 2Health News:Emageon Reports Third Quarter 2007 Financial Results 3Health News:Emageon Reports Third Quarter 2007 Financial Results 4Health News:Emageon Reports Third Quarter 2007 Financial Results 5Health News:Emageon Reports Third Quarter 2007 Financial Results 6Health News:Emageon Reports Third Quarter 2007 Financial Results 7Health News:Emageon Reports Third Quarter 2007 Financial Results 8Health News:Emageon Reports Third Quarter 2007 Financial Results 9Health News:Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 2Health News:Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 3Health News:Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 4Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:Profarma's Gross Revenues Reached R$ 698.2 Million in the 3rd Quarter 2007, a 31.9% Growth Over the Same Period Last Year and Net Income Rose by 94.9%, Respectively 2
H. Pylori Rapid Test Strip
BioSign® H. pylori - Rapid H. pylori Antibody (IgM/IgG/IgA) Test
Clearview H. pylori II
TRINITY BIOTECH UNI-GOLD H. PYLORI TEST
Medicine Products: